Mednet Logo

How would you treat a locally recurrent triple negative breast cancer after achieving CR a year earlier to neoadjuvant ddAC-T, BCS and WBRT?

Would you consider use of immunotherapy with checking PDL1? What chemotherapy agents would you consider along with mastectomy/radiation?
1 Answer
Mednet Member
Mednet Member
Medical Oncology · University of Iowa Holden Comprehensive Cancer Center
Answered on · Updated on

I would recommend staging work up to rule out distant metastases for this patient with high-risk TNBC before committing this patient to local therapy.

Isolated Loco-regional recurrences (ILRR) are associated with a high risk of developing distant metastases and early recurrence (< 24 months, as in th...

Join for free or sign in to see the full answer